Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.040
-0.090 (-4.23%)
At close: Sep 17, 2025, 4:00 PM EDT
2.079
+0.039 (1.91%)
After-hours: Sep 17, 2025, 5:23 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $96.15 million as of September 17, 2025. Its market cap has decreased by -25.11% in one year.
Market Cap
96.15M
Enterprise Value
41.35M
1-Year Change
-25.11%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $96.15M, a decrease of -88.04%. That is a compound annual growth rate of -36.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 100.39M | 13.95% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |